ILK and cancer: In CRC, overexpression of ILK is associated with genomic instability, epithelial-mesenchymal transition (EMT), and cancer stem cells (CSCs) traits, which contribute to tumor progression, migration, invasion, and chemoresistance via NF-κB, CTEN signals, etc. [10–15].